Fabric Genomics (formerly Omicia)

Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Tad Buchanan

Director

1 past transactions

Spiral Genetics

Acquisition in 2017
Spiral Genetics, Inc. is a genomic bioinformatics company that specializes in developing advanced analysis software for detecting structural variants from next-generation sequencing data. Founded in 2009 and based in Seattle, Washington, the company focuses on providing tools that support medical, pharmaceutical, and agricultural research. Its flagship product, the BioGraph Suite, is an indexed graph-based platform designed for genomic data management and analysis. Additionally, Spiral Genetics offers Anchored Assembly, a method that accurately detects single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variants ranging from 10bp to 100kbp, utilizing existing sequencing data from platforms like HiSeq and MiSeq. This software reduces computational complexity by concentrating on non-reference sequence regions and employs a unique read overlap graph for variant detection. Spiral Genetics operates as a subsidiary of Omicia, Inc. and continues to enhance its offerings for effective DNA data analysis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.